Translational Lung Cancer Research

Translational Lung Cancer Research is an international, peer-reviewed, open access journal.

Translational Lung Cancer Research provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer and related thoracic diseases. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.

TLCR is dedicated to focus on cutting-edge developments at the transition from preclinical to clinical research and thus closes the gap between “bench and bedside”. The aim of TLCR is to provide a forum for the dissemination of original research and review articles in all areas related to lung cancer, as well as a timely platform for the exchange of key opinions between leading experts, and so to provide readers with a novel, well-organized, informative, enlightening and educational journal.

Platform:

OvidSP

Publisher:

AME Publishing Company

Product Type:

Journal

Author:

AME

ISSN:

2218-6751

Specialty:

• Internal Medicine
• Oncology
• Pulmonary Medicine

Language:

English

Update Frequency:

Semi-Monthly

2024 Journal Impact Factor:

3.5 (Journal Citation Report, Web of Science Group)